Evidence map›Paper›PMID 33486483›Full record

ReviewHormone research in paediatrics2020

Pediatric Endocrinology in the Time of COVID-19: Considerations for the Rapid Implementation of Telemedicine and Management of Pediatric Endocrine Conditions.

Molly O Regelmann, Rushika Conroy, Evgenia Gourgari, Anshu Gupta, Ines Guttmann-Bauman, Ryan Heksch, Manmohan K Kamboj, Sowmya Krishnan, Amit Lahoti, Kristal Matlock and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Hormone research in paediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Molly O RegelmannDivision of Pediatric Endocrinology and Diabetes, Children's Hospital at Montefiore, Albert Einstein School of Medicine, Bronx, New York, USA, moregelm@montefiore.org.
Rushika ConroyDivision of Pediatric Endocrinology, Baystate Children's Hospital, Springfield, Massachusetts, USA.
Evgenia GourgariDivision of Pediatric Endocrinology, Georgetown University, Washington, District of Columbia, USA.
Anshu GuptaDivision of Pediatric Endocrinology, Diabetes and Metabolism, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, Virginia, USA.
Ines Guttmann-BaumanDivision of Pediatric Endocrinology, Department of Pediatrics, OHSU (Oregon Health and Science University), Portland, Oregon, USA.
Ryan HekschCenter for Diabetes and Endocrinology, Department of Pediatrics, Akron Children's Hospital, Akron, Ohio, USA.
Manmohan K KambojDivision of Pediatric Endocrinology, Nationwide Children's Hospital at The Ohio State University, Columbus, Ohio, USA.
Sowmya KrishnanDivision of Pediatric Diabetes and Endocrinology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA.
Amit LahotiDivision of Endocrinology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Kristal MatlockDivision of Pediatric Endocrinology, Medical University of South Carolina, Charleston, South Carolina, USA.
PES Drug and Therapeutics Committee and Practice Management Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric endocrine practices had to rapidly transition to telemedicine care at the onset of the novel coronavirus disease 2019 (COVID-19) pandemic. For many, it was an abrupt introduction to providing virtual healthcare, with concerns related to quality of patient care, patient privacy, productivity, and compensation, as workflows had to change. SUMMARY: The review summarizes the common adaptations for telemedicine during the pandemic with respect to the practice of pediatric endocrinology and discusses the benefits and potential barriers to telemedicine. Key Messages: With adjustments to practice, telemedicine has allowed providers to deliver care to their patients during the COVID-19 pandemic. The broader implementation of telemedicine in pediatric endocrinology practice has the potential for expanding patient access. Research assessing the impact of telemedicine on patient care outcomes in those with pediatric endocrinology conditions will be necessary to justify its continued use beyond the COVID-19 pandemic.

Indexed as

TelemedicineChildCOVID-19Diabetes MellitusEndocrinologyHumansPandemicsPediatricsCoronavirus disease 2019DiabetesPediatric endocrinologyTelemedicine

Identifiers

PMID33486483
PMCPMC7900478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.